SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-21-002694
Filing Date
2021-08-13
Accepted
2021-08-13 08:03:17
Documents
3
Period of Report
2021-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2126454.htm 8-K 24033
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 127934
3 image00001.jpg GRAPHIC 21607
  Complete submission text file 0001178913-21-002694.txt   183122
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 211169790
SIC: 2834 Pharmaceutical Preparations